INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,509,000 | -89.9% | 202,000 | -82.5% | 0.08% | -87.8% |
| Q2 2019 | $14,941,000 | -18.4% | 1,152,900 | -23.3% | 0.62% | -7.7% |
| Q1 2019 | $18,308,000 | -27.9% | 1,503,100 | -32.6% | 0.67% | -61.3% |
| Q4 2018 | $25,383,000 | -11.9% | 2,228,500 | +67.8% | 1.74% | +22.1% |
| Q3 2018 | $28,824,000 | +40.8% | 1,328,300 | +14.6% | 1.42% | -7.6% |
| Q2 2018 | $20,473,000 | -4.7% | 1,159,300 | +13.5% | 1.54% | -20.4% |
| Q1 2018 | $21,492,000 | +251.2% | 1,021,000 | +141.5% | 1.94% | +336.5% |
| Q4 2017 | $6,120,000 | – | 422,700 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |